During the past decade, The Center for Clinical Research conducted 40 clinical trials. In the 10-year time frame, 40 clinical trials started and 56 clinical trials were completed, i.e. on average, 140% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 29 clinical trials were completed. i.e. 223.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Center for Clinical Research" #1 sponsor was "Boston Scientific Corporation" with 13 trials, followed by "Pfizer" with 12 trials sponsored, "Jazz Pharmaceuticals" with 5 trials sponsored, "Allergan" with 4 trials sponsored and "BioDelivery Sciences International" with 4 trials sponsored. Other sponsors include 64 different institutions and companies that sponsored additional 51 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Center for Clinical Research" #1 collaborator was "National Institute of Neurological Disorders and Stroke (NINDS)" with 2 trials as a collaborator, "United States Department of Defense" with 2 trials as a collaborator, "Anesthesia Pain Care Consultants, Tamarac, FL, USA" with 1 trials as a collaborator, "Boston Scientific Corporation" with 1 trials as a collaborator and "Camurus AB" with 1 trials as a collaborator. Other collaborators include 11 different institutions and companies that were collaborators in the rest 21 trials.

According to Clinical.Site data, the most researched conditions in "The Center for Clinical Research" are "Chronic Pain" (21 trials), "Pain" (16 trials), "Low Back Pain" (14 trials), "Back Pain" (9 trials) and "Fibromyalgia" (6 trials). Many other conditions were trialed in "The Center for Clinical Research" in a lesser frequency.

Most popular intervention types in "The Center for Clinical Research" are "Drug" (66 trials), "Device" (35 trials), "Other" (10 trials), "Biological" (8 trials) and "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (21 trials), "Buprenorphine" (4 trials), "SPRINT Peripheral Nerve Stimulation (PNS) System" (4 trials), "placebo" (4 trials) and "Relamorelin" (3 trials). Other intervention names were less common.

The vast majority of trials in "The Center for Clinical Research" are 107 trials for "All" genders.

Currently, there are NaN active trials in "The Center for Clinical Research". undefined are not yet recruiting, 10 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 68 completed trials in The Center for Clinical Research, 1 suspended trials, and 18 terminated clinical trials to date.

Out of the total trials that were conducted in The Center for Clinical Research, 2 "Phase 1" clinical trials were conducted, 25 "Phase 2" clinical trials and 42 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 31 trials that are defined as “Not Applicable".